TURNAROUND IS ON FOR LEXARIA Bioscience Corp/Lexar
Post# of 4861
(Total Views: 168)
Posted On: 09/16/2020 6:12:18 PM
TURNAROUND IS ON FOR LEXARIA Bioscience Corp/Lexaria Corp.
Lexaria Bioscience Corp (LXX.CN)
0.375 +0.025 (+7.14%) 09/16/20 [CNSX]
QUOTE OVERVIEW for Wed, Sep 16th, 2020Alerts Watch Help
Day Low
0.365
Day High
0.375
Open 0.375
Previous Close0.350
Volume19,950
Avg Vol41,593
Stochastic %K18.89%
Weighted Alpha-60.10
5-Day Change+0.005 (+1.35%)
52-Week Range0.310 - 0.990
since 09/16/19
Most Recent Stories
Lexaria Bioscience Supports Corporate Growth Initiatives by its Licensee, Cannadips CBD by the Boldt Runners Corporation
TheNewswire.ca - Wed Sep 16, 5:25AM CDT
(via TheNewswire)
LXX.CN : 0.375 (+7.14%)
Lexaria Bioscience Announces R&D Agreement With British American Tobacco
ACCESSWIRE - Mon Aug 31, 3:02PM CDT
KELOWNA, BC / ACCESSWIRE / August 31, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"
, a global innovator in drug delivery platforms, announces that it has entered a...
LXX.CN : 0.375 (+7.14%)
Lexaria Bioscience to Present at the LD 500 Virtual Conference
ACCESSWIRE - Thu Aug 20, 6:17AM CDT
Company to discuss its Phase I R&D program with Altria Ventures Inc., for oral forms of nicotine delivery utilizing its patented DehydraTECH™ technology
LXRP : 0.2835 (+4.00%) LXX.CN : 0.375 (+7.14%)
Medical Marijuana Market 2020 Industry Size, Growth, Trends, Segments and Cost Structure Analysis Research Report 2028
AmericaNewsHour - Mon Aug 3, 7:25AM CDT
Research Nester published a report titled which delivers a detailed overview of the medical marijuana market in terms of market segmentation by end- user, by product, by application, and by region.
Lexaria Announces 2020 Annual and Special Meeting Results
TheNewswire.ca - Wed Jun 24, 5:15AM CDT
(via TheNewswire)
LXRP : 0.2835 (+4.00%) LXX.CN : 0.375 (+7.14%)
Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives New Expanded Health Canada License
TheNewswire.ca - Thu Jun 18, 5:30AM CDT
(via TheNewswire)
LXRP : 0.2835 (+4.00%) LXX.CN : 0.375 (+7.14%)
Medical Marijuana Market To Grow During 2020-28 On Account Of Increasing Adult Patients With Chronic Diseases
AmericaNewsHour - Wed Jun 17, 6:52AM CDT
Research Nester published a report titled which delivers a detailed overview of the medical marijuana market in terms of market segmentation by end- user, by product, by application, and by region.
Marijuana Market Trends, Share, Size, Growth, Supply and Manufacturers Analysis Research Report 2025
AmericaNewsHour - Wed Jun 17, 3:38AM CDT
Global Marijuana Market was valued at USD 17.2 Billion in the year 2017. Global Marijuana Market is further estimated to grow at a CAGR of 22.9% from 2019 to reach USD 88.97 Billion by the year 2025. North...
Barchart Technical Opinion LXRP Lexaria Bioscience Corp.
The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.
The market is approaching oversold territory. Be watchful of a trend reversal.
Lexaria Bioscience Corp (LXX.CN)
0.375 +0.025 (+7.14%) 09/16/20 [CNSX]
QUOTE OVERVIEW for Wed, Sep 16th, 2020Alerts Watch Help
Day Low
0.365
Day High
0.375
Open 0.375
Previous Close0.350
Volume19,950
Avg Vol41,593
Stochastic %K18.89%
Weighted Alpha-60.10
5-Day Change+0.005 (+1.35%)
52-Week Range0.310 - 0.990
since 09/16/19
Most Recent Stories
Lexaria Bioscience Supports Corporate Growth Initiatives by its Licensee, Cannadips CBD by the Boldt Runners Corporation
TheNewswire.ca - Wed Sep 16, 5:25AM CDT
(via TheNewswire)
LXX.CN : 0.375 (+7.14%)
Lexaria Bioscience Announces R&D Agreement With British American Tobacco
ACCESSWIRE - Mon Aug 31, 3:02PM CDT
KELOWNA, BC / ACCESSWIRE / August 31, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"
, a global innovator in drug delivery platforms, announces that it has entered a... LXX.CN : 0.375 (+7.14%)
Lexaria Bioscience to Present at the LD 500 Virtual Conference
ACCESSWIRE - Thu Aug 20, 6:17AM CDT
Company to discuss its Phase I R&D program with Altria Ventures Inc., for oral forms of nicotine delivery utilizing its patented DehydraTECH™ technology
LXRP : 0.2835 (+4.00%) LXX.CN : 0.375 (+7.14%)
Medical Marijuana Market 2020 Industry Size, Growth, Trends, Segments and Cost Structure Analysis Research Report 2028
AmericaNewsHour - Mon Aug 3, 7:25AM CDT
Research Nester published a report titled which delivers a detailed overview of the medical marijuana market in terms of market segmentation by end- user, by product, by application, and by region.
Lexaria Announces 2020 Annual and Special Meeting Results
TheNewswire.ca - Wed Jun 24, 5:15AM CDT
(via TheNewswire)
LXRP : 0.2835 (+4.00%) LXX.CN : 0.375 (+7.14%)
Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives New Expanded Health Canada License
TheNewswire.ca - Thu Jun 18, 5:30AM CDT
(via TheNewswire)
LXRP : 0.2835 (+4.00%) LXX.CN : 0.375 (+7.14%)
Medical Marijuana Market To Grow During 2020-28 On Account Of Increasing Adult Patients With Chronic Diseases
AmericaNewsHour - Wed Jun 17, 6:52AM CDT
Research Nester published a report titled which delivers a detailed overview of the medical marijuana market in terms of market segmentation by end- user, by product, by application, and by region.
Marijuana Market Trends, Share, Size, Growth, Supply and Manufacturers Analysis Research Report 2025
AmericaNewsHour - Wed Jun 17, 3:38AM CDT
Global Marijuana Market was valued at USD 17.2 Billion in the year 2017. Global Marijuana Market is further estimated to grow at a CAGR of 22.9% from 2019 to reach USD 88.97 Billion by the year 2025. North...
Barchart Technical Opinion LXRP Lexaria Bioscience Corp.
The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.
The market is approaching oversold territory. Be watchful of a trend reversal.
(1)
(0)
Robert
Scroll down for more posts ▼